Type 1 Diabetes: Epidemiology Forecast to 2026

Type 1 diabetes, formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops in children or young adults before the age of 40 years. The condition, therefore, was also referred to as juvenile diabetes. Type 1 diabetes accounts for about 5–10% of all diabetes cases and occurs as a result of the autoimmune destruction of pancreatic beta cells, which are responsible for producing insulin, a hormone that regulates blood sugar. If the condition is left untreated, blood sugar levels accumulate. In addition to the pancreas, high levels of blood sugar can damage other major organs, such as the heart, blood vessels, nerves, eyes, and kidneys. Such damage can be life threatening. Furthermore, research suggests that the incidence of type 1 diabetes is increasing globally, which may lead to an increased burden on healthcare resources (Holt, 2004; World Health Organization, 2013; Mayo Clinic, 2017).

To forecast the diagnosed prevalent cases of type 1 diabetes in the 8MM, GlobalData epidemiologists selected nationally representative population-based studies that provided data for the diagnosed prevalence of type 1 diabetes in the 8MM.

In the 8MM, the diagnosed prevalent cases of type 1 diabetes will increase from 3,396,254 cases in 2016 to 4,725,990 cases in 2026, at an Annual Growth Rate (AGR) of 3.92% per year. Among the 8MM, the US had the highest number of diagnosed prevalent cases of type 1 diabetes in 2016 and 2026, at 1,564,973 cases and 2,274,873 cases, respectively. Canada had the lowest number of prevalent cases of type 1 diabetes in 2016 and 2026, at 163,113 cases and 254,166 cases, respectively. GlobalData epidemiologists attribute the increase in the diagnosed prevalent cases of type 1 diabetes in the 8MM to environmental factors (seasonal variation) coupled with genetic factors, such as a family history of type 1 diabetes. However, further research is necessary to clearly understand the epidemiological factors responsible for the growth in the prevalent cases of type 1 diabetes (Onkamo et al., 1999).

Scope

The Type 1 Diabetes Epidemiology Report and Model provide an overview of the risk factors and global trends of type 1 diabetes in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada).

The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of type 1 diabetes segmented by age (ages under 20 years, 20–29 years, 30–44 years, 45–59 years, 60–74 years, and 75 years and older) and sex in these markets. To forecast the diagnosed prevalent cases of type 1 diabetes in the 8MM, GlobalData epidemiologists selected nationally representative population-based studies that provided data for the diagnosed prevalence of type 1 diabetes in the 8MM.

The type 1 diabetes epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.

 The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

 The Epidemiology Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The Type 1 Diabetes Epidemiology series will allow you to:

Develop business strategies by understanding the trends shaping and driving the global type 1 diabetes market.

Quantify patient populations in the global type 1 diabetes market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for type 1 diabetes therapeutics in each of the markets covered.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Type 1 Diabetes: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Type 1 Diabetes: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods

3.5 Epidemiological Forecast for Type 1 Diabetes (2016–2026)

3.5.1 Diagnosed Prevalent Cases of Type 1 Diabetes

3.5.2 Age-Specific Diagnosed Prevalent Cases of Type 1 Diabetes

3.5.3 Sex-Specific Diagnosed Prevalent Cases of Type 1 Diabetes

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

4.1 Bibliography

4.2 Abbreviations

4.3 About the Authors

4.3.1 Epidemiologist

4.3.2 Reviewers

4.3.3 Global Director of Therapy Analysis and Epidemiology

4.3.4 Global Head and EVP of Healthcare Operations and Strategy

4.4 About GlobalData

4.5 Contact Us

4.6 Disclaimer

List of Tables

Table 1: Risk Factors and Comorbidities for Type 1 Diabetes

Table 1: Risk Factors and Comorbidities for Type 1 Diabetes

List of Figures

Figure 1: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, Both Sexes, N, 2016 and 2026

Figure 2: 8MM, Diagnosed Prevalence (%) of ...

Figure 1: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, Both Sexes, N, 2016 and 2026

Figure 2: 8MM, Diagnosed Prevalence (%) of Type 1 Diabetes, Men, All Ages, 2006–2026

Figure 3: 8MM, Diagnosed Prevalence (%) of Type 1 Diabetes, Women, All Ages, 2006–2026

Figure 4: 8MM, Sources Used and Not Used, Diagnosed Prevalent Cases of Type 1 Diabetes

Figure 5: 8MM, Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, Both Sexes, N, 2016

Figure 6: 8MM, Age-Specific Diagnosed Prevalent Cases of Type 1 Diabetes, Both Sexes, N, 2016

Figure 7: 8MM, Sex-Specific Diagnosed Prevalent Cases of Type 1 Diabetes, All Ages, N, 2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports